Waters Corporation (WAT)

NYSE: WAT · IEX Real-Time Price · USD
344.50
-0.69 (-0.20%)
Mar 28, 2024, 12:43 PM EDT - Market open

Company Description

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe.

It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments.

In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing.

Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research.

Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications.

The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Waters Corporation
Waters logo
Country United States
Founded 1958
IPO Date Nov 16, 1995
Industry Diagnostics & Research
Sector Healthcare
Employees 7,900
CEO Dr. Udit Batra Ph.D.

Contact Details

Address:
34 Maple St
Milford, Massachusetts 01757
United States
Phone (508) 478-2000
Website waters.com

Stock Details

Ticker Symbol WAT
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001000697
CUSIP Number 941848103
ISIN Number US9418481035
Employer ID 13-3668640
SIC Code 3826

Key Executives

Name Position
Dr. Udit Batra Ph.D. President, Chief Executive Officer and Director
Amol Chaubal Senior Vice President and Chief Financial Officer
Keeley A. Aleman Senior Vice President, General Counsel and Corporate Secretary
Jianqing Y. Bennett Senior Vice President of TA Instruments Division and Waters Clinical Business Unit
Christos Ross Senior Vice President of Global Operations and Interim Senior VP of the Waters Division
Caspar Tudor Director of Investor Relations
Kristen Garvey Vice President of Corporate Communications
Patrick Conway Interim Vice President of Human Resources
Dr. Daniel Rush Ph.D. Senior Vice President of Strategy and Transformation
John Lynch Treasurer

Latest SEC Filings

Date Type Title
Mar 27, 2024 PRE 14A Other preliminary proxy statements
Mar 13, 2024 144 Filing
Feb 27, 2024 10-K Annual Report
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 9, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Feb 6, 2024 8-K Current Report
Jan 24, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 24, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 9, 2024 8-K Current Report